| C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer (NCT02344810) | Eastern Cooperative Oncology Group | 2015-03-06 |
| Fish Oil Supplementation in Gastrointestinal Cancer (NCT02699047) | Universidade Federal de Santa Catarina | 2015-03-01 |
| A Feasibility Trial of Geriatric Assessment and Management for Older Cancer Patients (NCT02222259) | University of Toronto | 2014-09-01 |
| The Laparotomy Study (NCT02140593) | Herlev Hospital | 2014-09-01 |
| Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology Patients (NCT02785887) | Azienda USL 4 Prato | 2014-08-01 |
| Efficacy of Radiotherapy in Combination With Zoledronic Acid in Bone Metastasis Patients With Gastrointestinal Tumors (NCT02784652) | Severance Hospital | 2014-06-01 |
| Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer (NCT02092298) | M.D. Anderson Cancer Center | 2014-05-08 |
| Study of Parenteral Nutrition to Patients With Gastrointestinal Cancer (NCT02066363) | Odense University Hospital | 2014-03-01 |
| Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine (NCT01845337) | University of Edinburgh | 2014-02-05 |
| Effect of COX-2 Selective Inhibitors on Postoperative Insulin Resistance After Gastrointestinal Laparoscopic Surgery (NCT01930318) | Jinling Hospital, China | 2013-08-01 |
| Electronic Patient Reported Symptom Assessment (NCT01833637) | Northwestern University | 2012-10-01 |
| Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers (NCT00716209) | Haematology-Oncology | 2012-09-01 |
| Collecting Solid Tumor Tissue to Identify New Treatments (NCT01658917) | National Cancer Institute (NCI) | 2012-07-24 |
| Immunonutrition and Quality of Life of Cancer Patients Undergoing Oncological Treatment (NCT01423799) | Société des Produits Nestlé (SPN) | 2012-07-01 |
| Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination Chemotherapy (NCT01504711) | Philip Philip | 2012-06-01 |
| Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer (NCT01608646) | Xijing Hospital | 2012-03-01 |
| Nutrition and Physical Exercise Study (NCT01540968) | Kantonsspital Winterthur KSW | 2012-03-01 |
| Rocking Motion: Physiologic Effect on the Surgical Stress Response (NCT01200316) | M.D. Anderson Cancer Center | 2012-02-01 |
| Patient Factors Impacting Adherence to Oral Chemotherapy (NCT01487343) | Memorial Sloan Kettering Cancer Center | 2011-11-01 |
| Biomarker Analysis of Gastrointestinal Cancer (NCT01484444) | Samsung Medical Center | 2011-09-01 |
| Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers (NCT01375699) | Virginia Commonwealth University | 2011-08-11 |
| Proton Radiotherapy for Upper Gastrointestinal Malignancies (NCT01449864) | Abramson Cancer Center at Penn Medicine | 2011-08-01 |
| Pilot Study of Strength and Balance Training Program for Persons With Oxaliplatin Induced Neuropathy (NCT01422993) | H. Lee Moffitt Cancer Center and Research Institute | 2011-07-01 |
| HYPAZ: Hypertension Induced by Pazopanib (NCT01392352) | Cambridge University Hospitals NHS Foundation Trust | 2011-04-01 |
| Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer (NCT01313442) | National Cancer Institute (NCI) | 2011-03-02 |
| Tasigna Neoadjuvant Gastrointestinal Stromal Tumor (GIST) (NCT01270893) | M.D. Anderson Cancer Center | 2011-01-01 |
| CAPOX in KRAS Wild-Type Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater (NCT01202409) | M.D. Anderson Cancer Center | 2010-11-02 |
| A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy (NCT02130427) | Abramson Cancer Center at Penn Medicine | 2010-09-01 |
| Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer (NCT01116791) | Baki Topal | 2010-07-01 |
| Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid Tumors (NCT00855452) | Hadassah Medical Organization | 2009-01-01 |
| Home Enteral Nutrition in Malnourished Patients With Gastrointestinal Cancer (NCT02664974) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2008-12-01 |
| A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma (NCT00752570) | Amgen | 2008-11-01 |
| Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC) (NCT00788957) | NantBioScience, Inc. | 2008-10-27 |
| Validating M.D. Anderson Symptom Inventory (MDASI-GI) in GI Cancer Patients Under Chemotherapy (NCT00849979) | M.D. Anderson Cancer Center | 2008-07-01 |
| Study of Tivozanib (AV-951) Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestinal Cancers (NCT00660153) | AVEO Pharmaceuticals, Inc. | 2008-06-01 |
| Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma (NCT00583674) | Amgen | 2007-12-01 |
| Screening to Predict Weight Loss in Patients With Cancer (NCT00710632) | Queen's Medical Center | 2007-09-01 |
| Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers (NCT00539318) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-08-01 |
| Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer (NCT00436410) | National Institutes of Health Clinical Center (CC) | 2006-12-01 |
| Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients (NCT00513357) | M.D. Anderson Cancer Center | 2006-06-01 |
| Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo (NCT00332280) | Auron Healthcare GmbH | 2006-05-01 |
| Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors (NCT00356889) | National Cancer Institute (NCI) | 2006-05-01 |
| Effects of 3 Day Preoperative Immunonutrition in Well-nourished Patients With Gastrointestinal (GI) Cancer Undergoing Surgery (NCT01023412) | Société des Produits Nestlé (SPN) | 2006-01-01 |
| Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs) (NCT00089960) | Amgen | 2004-10-01 |
| Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal Function (NCT00094965) | Sanofi | 2004-09-01 |
| Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients (NCT00516269) | M.D. Anderson Cancer Center | 2004-08-01 |
| Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors (NCT00086762) | M.D. Anderson Cancer Center | 2004-06-01 |
| Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder (NCT00085410) | National Cancer Institute (NCI) | 2004-01-01 |
| Harvesting Cells for Experimental Cancer Treatments (NCT00068003) | National Cancer Institute (NCI) | 2003-09-08 |
| Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract (NCT00353015) | M.D. Anderson Cancer Center | 2003-03-01 |
| A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gastric or Rectal Patients (NCT00254436) | M.D. Anderson Cancer Center | 2001-10-31 |
| Dietary Nitrate and Nitrite Intake and Phosphate Biomarkers and Risk of Chronic Diseases (NCT07746310) | Karolinska Institutet | 1987-01-01 |
| Long-term Cancer Risk in the Randomised Oslo Diet and Antismoking Study (NCT03410641) | Oslo University Hospital | 1972-01-15 |